Lin Pei
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Pituitary Gland Disorders and Treatments 10
- Growth Hormone and Insulin-like Growth Factors 3
-
- Cancer, Hypoxia, and Metabolism 9
- Co-authors
- Shlomo Melmed (7 shared papers)Kálmán Kovács (2 shared papers)B. Scheithauer (2 shared papers)Dara Y. Kallop (2 shared papers)Wenwen Chien (1 shared paper)Scott Powers (3 shared papers)Timothy Hoey (3 shared papers)Mei Jia (16 shared papers)
- Journals
- Journal of Biological Chemistry (8 papers)Biochemical Journal (3 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Clinica Chimica Acta (2 papers)Molecular Endocrinology (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Lin Pei
48 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 103
- Endocrinology, Diabetes and Metabolism 928
- Cancer Research 426
- Genetics 279
- Immunology 417
- Molecular Biology 1.3k
Countries citing papers authored by Lin Pei
This map shows the geographic impact of Lin Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Pei more than expected).
Fields of papers citing papers by Lin Pei
This network shows the impact of papers produced by Lin Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Pei. The network helps show where Lin Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 480 | |
| 2 | 2009 | 251 | |
| 3 | 2003 | 217 | |
| 4 | 2010 | 203 | |
| 5 | Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. | 1995 | 185 |
| 6 | 1994 | 174 | |
| 7 | 2003 | 146 | |
| 8 | 2001 | 141 | |
| 9 | 1991 | 109 | |
| 10 | 2000 | 98 | |
| 11 | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 2002 | 86 |
| 12 | 2000 | 67 | |
| 13 | 2017 | 61 | |
| 14 | 2001 | 59 | |
| 15 | 2011 | 56 | |
| 16 | 2021 | 52 | |
| 17 | 2019 | 51 | |
| 18 | 1999 | 41 | |
| 19 | 1996 | 40 | |
| 20 | 1996 | 39 |
About Lin Pei
Lin Pei is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Molecular Biology, Neurology and Oncology, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (9 papers), Epigenetics and DNA Methylation (6 papers), Neuroblastoma Research and Treatments (5 papers), Reproductive Biology and Fertility (4 papers), TGF-β signaling in diseases (3 papers), RNA modifications and cancer (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (928 citations), Cancer Research (426 citations), Genetics (279 citations), Immunology (417 citations) and Molecular Biology (1.3k citations). Lin Pei has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Shlomo Melmed, Kálmán Kovács, B. Scheithauer, Dara Y. Kallop, Wenwen Chien, Scott Powers, Timothy Hoey, Mei Jia, Jinfeng Liu and Diane Prager. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal, The Journal of Clinical Endocrinology & Metabolism, Clinica Chimica Acta and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.